Notably, elevated expression levels of CHMP5 and SLC38A1 in whole blood were associated with a shorter life expectancy in patients.300 These findings provide insights into potential new diagnostic and/or prognostic biomarkers for ALS. Here, CHMP5 is linked to amyotrophic lateral sclerosis.